Gilead Sciences to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8
December 21 2017 - 4:01PM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its
corporate presentation will be webcast from the 36th Annual J.P.
Morgan Healthcare Conference in San Francisco.
John F. Milligan, PhD, Gilead’s President and Chief Executive
Officer, will provide an overview of the company at the conference
on Monday, January 8 at 3:30 p.m. Pacific Time (6:30 p.m. Eastern
Time).
The live webcast can be accessed at the company’s Investors page
at www.gilead.com/investors. Please connect to the company’s
website at least 15 minutes prior to the start of the presentation
to ensure adequate time for any software download that may be
required to listen to the webcast. The replay will be available for
14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171221005739/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024